Visus Therapeutics Inc. – Trademark Portfolio
Entity Type: 03
Visus Therapeutics Inc. holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered and 4 are pending. Notable registered marks include BRIO, BRIMOCHOL, and VISUS THERAPEUTICS. The owner is based in Seattle, WA.
500 Yale Avenue North
Seattle, WA 98109
Showing of trademarks Trademarks
Trademark Classifications
Visus Therapeutics Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Visus Therapeutics Inc. have?
Visus Therapeutics Inc. has 18 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 pending, 11 abandoned.
What trademark classes does Visus Therapeutics Inc. file in?
Visus Therapeutics Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Visus Therapeutics Inc.'s most well-known trademarks?
Visus Therapeutics Inc.'s registered trademark portfolio includes well-known marks such as BRIO, BRIMOCHOL, and VISUS THERAPEUTICS. These are among 3 currently registered trademarks in the portfolio.
What is Visus Therapeutics Inc.'s trademark registration success rate?
Visus Therapeutics Inc. has a 21% trademark registration rate, with 3 out of 14 resolved applications resulting in successful registration. Currently, 4 applications are pending review.